Pristiq Related Clinical Trials
Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder [Completed]
Desvenlafaxine in Opioid-Dependent Patients [Recruiting]
12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder [Completed]
Desvenlafaxine vs. Placebo Treatment of Chronic Depression [Recruiting]
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women [Recruiting]
Desvenlafaxine Monotherapy in Dysthymia [Completed]
Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression [Recruiting]
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) [Completed]
Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects [Completed]
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients [Completed]
Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females [Completed]
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder [Completed]
Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet [Completed]
Omega 3 FA Supplements as Augmentation in the Treatment of Depression [Recruiting]
Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers [Recruiting]
Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR) [Completed]
Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD) [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder [Completed]
Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects [Completed]
Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) [Completed]
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder [Recruiting]
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder [Completed]
Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women [Completed]
Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects [Completed]
The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms [Completed]
Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder [Completed]
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder [Completed]
Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder [Completed]
Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder [Completed]
Neurocognition and Work Productivity in Major Depressive Disorder (MDD) [Completed]
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis [Recruiting]
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD [Active, not recruiting]
Safety, Tolerability and Pharmacokinetics Study of LY03005 [Completed]
Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women [Completed]
Efficacy of Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Treatment on Prefrontality in Patients With Generalized Anxiety Disorder (GAD) and Other Comorbidities [Recruiting]
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder [Completed]
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women [Completed]
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD [Completed]
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder [Completed]
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD [Active, not recruiting]
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD [Recruiting]
A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia [Terminated]
Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder [Completed]
Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy [Terminated]
Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Completed]
Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury [Completed]
Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy [Terminated]
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women [Completed]
Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1 [Recruiting]
Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome [Completed]
Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway [Completed]
Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder [Completed]
Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD [Completed]
Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005 [Completed]
Effects of Treatment on Decision-making in Major Depression [Active, not recruiting]
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder [Completed]
Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers [Completed]
Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Completed]
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions [Completed]
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions [Completed]
Venlafaxine 25 mg Tablets Under Fasting Conditions [Completed]
Venlafaxine 25 mg Tablets Under Non-Fasting Conditions [Completed]
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause [Completed]
Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause [Completed]
Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT) [Completed]
TRIAD - Treatment of Insomnia and Depression [Active, not recruiting]
|